Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer
- PMID: 12907136
- DOI: 10.1016/s0952-3278(03)00108-x
Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer
Abstract
Irrigation with taurolidine after laparoscopy decreases tumor growth in colon carcinoma. In pancreatic cancer subcutaneous therapy with octreotide decreases oxidative stress and carcinogenesis as well. However, it is still unclear, whether irrigation with taurolidine or octreotide after laparoscopic pancreatic biopsy reduces tumor growth in pancreatic cancer as well. In 60 Syrian hamsters ductal pancreatic adenocarcinoma was induced by weekly injection of 10mg/kg body weight N-nitrosobis-2-oxopropylamine s.c. for 10 weeks. In week 16 laparoscopic pancreatic biopsy by use of carbon dioxide was performed (gr. 1, n = 20) with subsequent laparoscopic irrigation with taurolidine (gr. 2, n = 20) or octreotide (gr. 3, n = 20). In week 25 hamsters were sacrificed. Our results show that macroscopic visible primary tumors were found in only one animal of the taurolidine group (5.9%), compared to 42.1% in the saline and 62.5% in the octreotide group (P<0.05). Carcinomas were smaller after saline (6+/-23 mm(2)) than after octreotide irrigation (70+/-120 mm(2), P<0.05). In conclusion this study showed that laparoscopic irrigation with taurolidine after pancreatic biopsy inhibited tumor growth in ductal pancreatic adenocarcinoma.
Similar articles
-
Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer.Clin Exp Metastasis. 2002;19(2):169-73. doi: 10.1023/a:1014579718391. Clin Exp Metastasis. 2002. PMID: 11964081
-
Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.Invest New Drugs. 2005 Mar;23(2):157-64. doi: 10.1007/s10637-005-5861-x. Invest New Drugs. 2005. PMID: 15744592
-
Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.Clin Exp Metastasis. 2009;26(7):719-27. doi: 10.1007/s10585-009-9271-x. Epub 2009 Jun 12. Clin Exp Metastasis. 2009. PMID: 19521786
-
Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.Anticancer Drugs. 2005 Oct;16(9):917-21. doi: 10.1097/01.cad.0000176502.40810.b0. Anticancer Drugs. 2005. PMID: 16162968 Review.
-
The evolving role of taurolidine in cancer therapy.Ann Surg Oncol. 2010 Apr;17(4):1135-43. doi: 10.1245/s10434-009-0867-9. Epub 2009 Dec 29. Ann Surg Oncol. 2010. PMID: 20039217 Review.
Cited by
-
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo.BMC Cancer. 2017 Mar 24;17(1):216. doi: 10.1186/s12885-017-3204-x. BMC Cancer. 2017. PMID: 28340556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources